LLY Eli Lilly and Company

Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Pharmaceuticals > Pharmaceuticals  | NYSE, MegaCap, ObesityDrugs |  Last Price: 1051.99 | 2026-02-27 | Atrp: 3.4

Sat 21 Feb 2026 to Thu 26 Feb 2026: Score -2

Metric		Previous	New	Change	Interpretation
❌	Enterprise Value/EBITDA	31.1606	39.2277	▲ 25.89%	Bearish. Lower is better. Significant decline Enterprise value to earnings before interest, taxes, depreciation
❌	Price Book MRQ	35.8899	40.2213	▲ 12.07%	Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter
❌	Enterprise Value	$987.57B	$771.32B	▼ -21.9%	Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash
❌	Price Sales TTM	14.6111	14.792	▲ 1.24%	Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months
✅	Enterprise Value/Revenue	15.1517	14.4826	▼ -4.42%	Bullish. Lower is better. Slight improvement Enterprise value divided by revenue
✅	Short Percent	0.88%	0.75%	▼ -14.77%	Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short
✅	Short Ratio	2.48	1.81	▼ -27.02%	Bullish. Lower is better. Significant improvement

Sat 14 Feb 2026 to Sat 21 Feb 2026: Score 3

Metric		Previous	New	Change	Interpretation
✅	Book Value	26.56	29.655	▲ 11.65%	Bullish. Higher is better. Moderate increase; stock now trades closer to book value Net asset value of the company per share
✅	Return On Assets TTM	17.6%	19.42%	▲ 10.34%	Bullish. Higher is better. Return on assets TTM growth accelerating. Efficiency in generating profits from total assets
✅	Forward PE	30.7692	27.1739	▼ -11.68%	Bullish. Lower is better. Moderate improvement Stock price divided by expected future earnings
✅	Enterprise Value	$964.51B	$987.57B	▲ 2.39%	Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash
✅	Institutional Ownership	83.755%	84.697%	▲ 1.12%	Bullish. Higher is better. Slight increase; continued strong interest from big investors Percentage held by institutions like mutual funds
❌	PEG Ratio	0.8879	0.8974	▲ 1.07%	Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate
❌	Operating Margin TTM	46.58%	44.9%	▼ -3.61%	Bearish. Higher is better. Operating margin TTM growth slowing. Percentage of revenue left after operating expenses
❌	Price Sales TTM	14.3039	14.6111	▲ 2.15%	Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months
❌	Price Book MRQ	35.0206	35.8899	▲ 2.48%	Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter
❌	Enterprise Value/Revenue	14.7978	15.1517	▲ 2.39%	Bearish. Lower is better. Slight decline Enterprise value divided by revenue
❌	Enterprise Value/EBITDA	30.4328	31.1606	▲ 2.39%	Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation
❌	Return On Equity TTM	108.28%	101.16%	▼ -6.58%	Bearish. Higher is better. Return on equity TTM growth slowing. Efficiency in generating profits from shareholders' equity

Fri 06 Feb 2026 to Sat 14 Feb 2026: Score 12

Metric		Previous	New	Change	Interpretation
✅	PEG Ratio	0.9282	0.8879	▼ -4.34%	Bullish. Lower is better. Slight decrease, improving the value relative to growth P/E ratio adjusted for growth rate
✅	Price Book MRQ	38.4003	35.0206	▼ -8.8%	Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter
✅	Enterprise Value/EBITDA	31.865	30.4328	▼ -4.49%	Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation
✅	Short Ratio	2.66	2.48	▼ -6.77%	Bullish. Lower is better. Slight improvement
✅	Short Percent	0.97%	0.88%	▼ -9.28%	Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short
✅	Wall Street Target Price	1186.1852	1201.6296	▲ 1.3%	Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock
✅	Price Sales TTM	14.554	14.3039	▼ -1.72%	Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months
✅	Enterprise Value	$946.26B	$964.51B	▲ 1.93%	Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash
❌	Enterprise Value/Revenue	14.5179	14.7978	▲ 1.93%	Bearish. Lower is better. Slight decline Enterprise value divided by revenue

Fri 30 Jan 2026 to Fri 06 Feb 2026: Score 17

Metric		Previous	New	Change	Interpretation
✅	EPS Estimate Current Year	23.6402	34.1476	▲ 44.45%	Bullish. Higher is better. Significant increase; improved outlook for current year earnings Expected earnings per share this year
✅	Earnings Per Share	20.64	22.96	▲ 11.24%	Bullish. Higher is better. Moderate increase in earnings per share Profit allocated to each outstanding share
✅	EPS Estimate Next Year	33.2155	41.5191	▲ 25%	Bullish. Higher is better. Significant raised expectations for further out Expected earnings per share next year
✅	Return On Equity TTM	96.47%	108.28%	▲ 12.24%	Bullish. Higher is better. Return on equity TTM growth accelerating. Efficiency in generating profits from shareholders' equity
✅	Enterprise Value/EBITDA	39.2277	31.865	▼ -18.77%	Bullish. Lower is better. Moderate improvement Enterprise value to earnings before interest, taxes, depreciation
✅	EBITDA	$28728.6M	$31577.73M	▲ 9.92%	Bullish. Higher is better. Increase in earnings before interest, taxes, depreciation, and amortization; indicates stronger operational cash flow Earnings before interest, taxes, depreciation, and amortization
✅	Gross Profit TTM	$49335.7M	$54127M	▲ 9.71%	Bullish. Higher is better. Slight increase, but margins may be improving Revenue minus cost of goods sold over the trailing twelve months
✅	Revenue TTM	$59419.8M	$65179M	▲ 9.69%	Bullish. Higher is better. Slight top-line expansion Total revenue over the trailing twelve months
✅	Revenue Per Share TTM	66.148	72.477	▲ 9.57%	Bullish. Higher is better. Slight improvement Revenue generated per outstanding share over the trailing twelve months
✅	Price Sales TTM	15.6473	14.554	▼ -6.99%	Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months
✅	Price Book MRQ	40.2213	38.4003	▼ -4.53%	Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter
✅	Wall Street Target Price	1146.2963	1186.1852	▲ 3.48%	Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock
✅	Profit Margin	30.99%	31.67%	▲ 2.19%	Bullish. Higher is better. Profit margin growth accelerating. Percentage of revenue that turns into profit
❌	PEG Ratio	0.8974	0.9282	▲ 3.43%	Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate
❌	Operating Margin TTM	48.29%	46.58%	▼ -3.54%	Bearish. Higher is better. Operating margin TTM growth slowing. Percentage of revenue left after operating expenses
❌	Quarterly Revenue Growth YOY	541%	431%	▼ -20.96%	Bearish. Higher is better. Quarterly revenue growth YOY growth slowing. Year-over-year growth in quarterly revenue
❌	Forward PE	27.1739	31.0559	▲ 14.29%	Bearish. Lower is better. Moderate decline Stock price divided by expected future earnings
❌	Quarterly Earnings Growth YOY	4801%	511%	▼ -89.3%	Bearish. Higher is better. Quarterly earnings growth YOY growth slowing. Year-over-year growth in quarterly earnings

Thu 22 Jan 2026 to Fri 30 Jan 2026: Score 6

Metric		Previous	New	Change	Interpretation
✅	Forward PE	33.2226	27.1739	▼ -18.21%	Bullish. Lower is better. Moderate improvement Stock price divided by expected future earnings
✅	Enterprise Value/Revenue	16.9273	14.4826	▼ -14.44%	Bullish. Lower is better. Moderate improvement Enterprise value divided by revenue
✅	PEG Ratio	0.9908	0.8974	▼ -9.43%	Bullish. Lower is better. Slight decrease, improving the value relative to growth P/E ratio adjusted for growth rate
✅	Price Sales TTM	16.4051	15.6473	▼ -4.62%	Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months
✅	Wall Street Target Price	1110.715	1146.2963	▲ 3.2%	Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock
✅	EPS Estimate Next Year	32.7964	33.2155	▲ 1.28%	Bullish. Higher is better. Slight raised expectations for further out Expected earnings per share next year
✅	Price Book MRQ	40.9033	40.2213	▼ -1.67%	Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter
✅	Enterprise Value/EBITDA	39.7609	39.2277	▼ -1.34%	Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation
❌	Enterprise Value	$997.89B	$949.22B	▼ -4.88%	Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash
❌	Short Ratio	2.33	2.66	▲ 14.16%	Bearish. Lower is better. Moderate decline
❌	Short Percent	0.87%	0.97%	▲ 11.49%	Bearish. Lower is better. Moderate increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short

Mon 05 Jan 2026 to Tue 13 Jan 2026: Score -5

Metric		Previous	New	Change	Interpretation
❌	Short Ratio	1.82	2.33	▲ 28.02%	Bearish. Lower is better. Significant decline
❌	Short Percent	0.82%	0.87%	▲ 6.1%	Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short
❌	Price Sales TTM	15.7131	16.2514	▲ 3.43%	Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months
✅	Wall Street Target Price	1098.0377	1116.3341	▲ 1.67%	Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock
✅	Earnings Per Share	19.68	20.36	▲ 3.46%	Bullish. Higher is better. Slight increase in earnings per share Profit allocated to each outstanding share

Sat 20 Dec 2025 to Mon 05 Jan 2026: Score 1

Metric		Previous	New	Change	Interpretation
✅	Short Percent	0.89%	0.82%	▼ -7.87%	Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short
✅	PEG Ratio	1.0045	0.9844	▼ -2%	Bullish. Lower is better. Slight decrease, improving the value relative to growth P/E ratio adjusted for growth rate
✅	Forward PE	33.67	33.0033	▼ -1.98%	Bullish. Lower is better. Slight improvement Stock price divided by expected future earnings
✅	Price Sales TTM	16.1646	15.7131	▼ -2.79%	Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months
❌	Earnings Per Share	20.36	19.68	▼ -3.34%	Bearish. Higher is better. Slight decline in earnings per share Profit allocated to each outstanding share
❌	Short Ratio	1.56	1.82	▲ 16.67%	Bearish. Lower is better. Moderate decline